142 filings
Page 3 of 8
8-K
oq0jng23gctqf29ln5y
10 Mar 22
Selecta Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results
8:00am
8-K
3kal5uhajg01a kd
16 Feb 22
February 2022 Selecta Biosciences Corporate Presentation SELB
8:00am
8-K
w6k04ximhq5cm
10 Feb 22
Other Events
8:00am
8-K
wvt zvoqh1o0g827ns1j
10 Jan 22
Other Events
7:05am
8-K
2cyt63
24 Nov 21
Selecta Biosciences Provides Update on Phase 1/2 Clinical Trial of SEL-302 for the Treatment of
4:22pm
8-K
v3q bje3d2ggza
9 Nov 21
Selecta Biosciences Reports Third Quarter 2021 Financial Results and Provides Business Update
8:00am
8-K
bqhv8nlei vb7l
8 Nov 21
Regulation FD Disclosure
8:06am
8-K
tvixd7zrxf3rsptnzhi
26 Oct 21
Other Events
8:00am
8-K
nutl86
25 Oct 21
Entry into a Material Definitive Agreement
8:06am
8-K
l23tw8
21 Oct 21
Other Events
8:00am
8-K
24vy62j
4 Oct 21
Other Events
8:00am
8-K
syd o0gj3fd
30 Sep 21
Amendments to Articles of Incorporation or Bylaws
8:00am
8-K
vm39y ud139uoxzk1
20 Sep 21
Departure of Directors or Certain Officers
8:00am
8-K
a2tnmld b7qcdt
8 Sep 21
Other Events
8:05am
8-K
ppkarbmwjtl chzsh
12 Aug 21
Selecta Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update
9:04am
8-K
k00qi4t32m4i0o
24 Jun 21
Departure of Directors or Certain Officers
8:15am
8-K
g7xc9k uh97m5mwdpj
21 Jun 21
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
u2iiucrlqy596um
13 May 21
Selecta Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
8:01am
8-K
k4khj 9cf3shvactv8
29 Apr 21
Selecta Biosciences and AskBio Announce Updates to Methylmalonic Acidemia (MMA-101) Program
9:04am
8-K
rijx4 v18d3n
15 Apr 21
Other Events
4:15pm